Nectin-4 Specific LMW PET Probe Imaging in Urothelial Carcinoma
NCT05321316
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Urothelial Carcinoma
Interventions
DRUG:
18F-FDG
Sponsor
Peking University Cancer Hospital & Institute